Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eve-3: a liver enriched suppressor of Ras/MAPK signaling.
King JA, Corcoran NM, D'Abaco GM, Straffon AF, Smith CT, Poon CL, Buchert M, I S, Hall NE, Lock P, Hovens CM. King JA, et al. Among authors: buchert m. J Hepatol. 2006 Apr;44(4):758-67. doi: 10.1016/j.jhep.2005.10.031. Epub 2005 Dec 12. J Hepatol. 2006. PMID: 16478641
An in vitro assay of beta-galactosidase from yeast.
Schneider S, Buchert M, Hovens CM. Schneider S, et al. Among authors: buchert m. Biotechniques. 1996 Jun;20(6):960-2. doi: 10.2144/96206bm03. Biotechniques. 1996. PMID: 8780862 Free article. No abstract available.
Useful vectors for the two-hybrid system in mammalian cells.
Buchert M, Schneider S, Adams MT, Hefti HP, Moelling K, Hovens CM. Buchert M, et al. Biotechniques. 1997 Sep;23(3):396-8, 400, 402. doi: 10.2144/97233bm10. Biotechniques. 1997. PMID: 9298205 Free article. No abstract available.
Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK.
Lau DK, Luk IY, Jenkins LJ, Martin A, Williams DS, Schoffer KL, Chionh F, Buchert M, Sjoquist K, Boussioutas A, Hayes SA, Ernst M, Weickhardt AJ, Pavlakis N, Tebbutt NC, Mariadason JM. Lau DK, et al. Among authors: buchert m. Mol Cancer Ther. 2021 Apr;20(4):704-715. doi: 10.1158/1535-7163.MCT-20-0836. Epub 2021 Feb 9. Mol Cancer Ther. 2021. PMID: 33563752 Clinical Trial.
96 results